Disclosure statement
Annie Im has performed consulting from Abbvie and CTI Biopharma and received research funding from Incyte. Alison Sehgal has received research funding from Kite/Gilead, Juno/BMS and Milltenyiz. Michael Boyiadzis is currently an adjunct professor of Medicine at the University of Pittsburgh and an employee of Genentech.